Newronika says first participant implanted in ADVENT pivotal study
The Milan-based medtech company said the first participant in its ADVENT study received the αDBS implant on Sept. 21 in Monza. The study is evaluating adaptive versus conventional deep brain stimulation for Parkinson's disease.